US prosecutors have charged two Indian nationals with allegedly importing and selling counterfeit Ozempic in America. The case centres on fake packaging, continued sales after an FDA warning, and the prospect of lengthy prison terms.

The suspects allegedly obtained counterfeit Ozempic in China and sold it to US distributors at discounted prices. Read more at straitstimes.com.